Association Between MDM2 Promoter SNP309 T/G Polymorphism and Liver Cancer Risk - a Meta-analysis
Authors:
- Hong-Bo MaHMHong-Bo Ma
- Tao HuangTHTao Huang
- Feng HanFHFeng Han
- Wei-Yu ChenWCWei-Yu Chen
Open Access
- 30 June 2012
- journal article
- research article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 13 (6) , 2841-2846
Abstract
Association Between MDM2 Promoter SNP309 T/G Polymorphism and Liver Cancer Risk - a Meta-analysis Liver cancer;MDM2;polymorphism;risk factor;meta-analysis; Background: Many studies have investigated the association between the MDM2 promoter SNP309 T/G polymorphism and liver cancer risk, but inconsistencies make drawwing definitive conclusions difficult. Methods: We therefore searched main databases for articles relating MDM2 SNP309 T/G polymorphism to risk of liver cancer in humans and estimated summary odds ratio (OR) with 95% confidence intervals (95% CI) to assess the possible association in a meta-analysis. Results: The main analysis revealed no significant heterogeneity, and the pooled ORs of fixed-effects were all significant (for G versus T, OR = 1.59, 95% CI 1.42-1.78; for GG versus TT, OR = 2.45, 95% CI 1.93-3.12; for GT versus TT, OR = 1.70, 95% CI 1.38-2.09; for GG versus GT, OR = 1.49, 95% CI 1.24-1.79; for GG and GT versus TT, OR = 1.95, 95% CI 1.61-2.38; for GG versus TT and GT, OR = 1.73, 95% CI 1.46-2.07). Subgroup analyses by ethnicity and sensitivity analyses both showed associations to remain significant. Conclusion: The present meta-analysis of available data showed a significant association between the MDM2 SNP309 T/G polymorphism and liver cancer risk, the MDM2 SNP309 G allele contributing to increased risk in both Asians and Caucasians in a graded, dose-dependent fashion.Keywords
This publication has 36 references indexed in Scilit:
- Murine double minute 2 regulates Hu antigen R stability in human liver and colon cancer through NEDDylationHepatology, 2011
- TP 53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patientsInfectious Agents and Cancer, 2011
- Impact of TP53 Codon 72 and MDM2 Promoter 309 Allelic Dosage in a Moroccan Population with Hepatocellular CarcinomaThe International Journal of Biological Markers, 2011
- Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in miceJournal of Clinical Investigation, 2010
- Iron-Dependent Regulation of MDM2 Influences p53 Activity and Hepatic CarcinogenesisThe American Journal of Pathology, 2010
- Correlation between expression of p53, p21/WAF1, and MDM2 proteins and their prognostic significance in primary hepatocellular carcinomaJournal of Translational Medicine, 2009
- Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysisBreast Cancer Research and Treatment, 2009
- A New Twist in the Feedback Loop: Stress-Activated MDM2 Destabilization is Required for p53 ActivationCell Cycle, 2005
- Measuring inconsistency in meta-analysesBMJ, 2003
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986